Published in Stroke on July 03, 2003
Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage (FITCH) | NCT04088630
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Sociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort study. BMJ (2009) 1.73
Statin use following intracerebral hemorrhage: a decision analysis. Arch Neurol (2011) 1.59
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation. Eur Heart J (2014) 1.54
Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ (2006) 1.51
Trends in substance abuse preceding stroke among young adults: a population-based study. Stroke (2012) 1.40
Advances in the management of intracerebral hemorrhage. Nat Rev Neurol (2010) 1.28
Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Front Neurol (2014) 1.27
The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke. Nat Commun (2011) 1.25
Update on intracerebral haemorrhage. J Neurol (2006) 1.19
Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics (2011) 1.16
Noncommunicable diseases: current status of major modifiable risk factors in Korea. J Prev Med Public Health (2013) 1.13
Low cholesterol as a risk factor for primary intracerebral hemorrhage: A case-control study. Ann Indian Acad Neurol (2012) 1.11
Individual and population benefits of daily aspirin therapy: a proposal for personalizing national guidelines. Circ Cardiovasc Qual Outcomes (2011) 1.11
Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort. Stroke (2008) 1.09
International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep (2012) 1.09
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol (2010) 1.08
Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons. Neurobiol Dis (2008) 1.05
Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation. Neurology (2012) 1.05
Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiatry (2005) 1.05
Progress in translational research on intracerebral hemorrhage: is there an end in sight? Prog Neurobiol (2013) 1.03
CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke (2009) 1.02
Experimental intracerebral hemorrhage: avoiding pitfalls in translational research. J Cereb Blood Flow Metab (2011) 1.02
Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke. Front Neurol (2013) 1.02
Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study. J Neurol (2008) 1.01
Alcohol and acute ischemic stroke onset: the stroke onset study. Stroke (2010) 1.00
Cost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillation. PLoS One (2012) 0.99
Risk factors for intracerebral hemorrhage: the REasons for geographic and racial differences in stroke (REGARDS) study. Stroke (2013) 0.99
Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective community-based cohorts. Stroke (2014) 0.97
Clinical review: Critical care management of spontaneous intracerebral hemorrhage. Crit Care (2008) 0.96
Increased risk of hemorrhagic stroke in patients with migraine: a population-based cohort study. PLoS One (2013) 0.95
Racial differences in microbleed prevalence in primary intracerebral hemorrhage. Neurology (2008) 0.93
Alcohol intake and noncoronary cardiovascular diseases. Ann Epidemiol (2007) 0.92
Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort. Neurology (2014) 0.92
Factors associated with early deterioration after spontaneous intracerebral hemorrhage: a systematic review and meta-analysis. PLoS One (2014) 0.90
Age-related comparisons of evolution of the inflammatory response after intracerebral hemorrhage in rats. Transl Stroke Res (2012) 0.89
Treatment targets in intracerebral hemorrhage. Neurotherapeutics (2011) 0.89
European research priorities for intracerebral haemorrhage. Cerebrovasc Dis (2011) 0.87
Does adhesive capsulitis of the shoulder increase the risk of stroke? A population-based propensity score-matched follow-up study. PLoS One (2012) 0.86
Vascular recovery promoted by atorvastatin and simvastatin after experimental intracerebral hemorrhage: magnetic resonance imaging and histological study. J Neurosurg (2010) 0.85
Risk Factors Associated With Incident Cerebral Microbleeds According to Location in Older People: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study. JAMA Neurol (2015) 0.84
Predictors of risk of intracerebral haemorrhage in patients with a history of TIA or minor ischaemic stroke. J Neurol Neurosurg Psychiatry (2006) 0.84
Risk factors for primary intracerebral hemorrhage in patients in Izumo City, Japan. Neurosurg Rev (2007) 0.84
Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke. J Neurol (2008) 0.84
Influence of stroke subtype on quality of care in the Get With The Guidelines-Stroke Program. Neurology (2009) 0.84
Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study. BMC Gastroenterol (2008) 0.83
A prospective cohort study of stroke characteristics, care, and mortality in a hospital stroke registry in Vietnam. BMC Neurol (2012) 0.82
Declining rates of fatal and nonfatal intracerebral hemorrhage: epidemiological trends in Australia. J Am Heart Assoc (2014) 0.82
Carotid intima-media thickness, electrocardiographic left ventricular hypertrophy, and incidence of intracerebral hemorrhage. Stroke (2011) 0.81
Risk of intracranial hemorrhage associated with autosomal dominant polycystic kidney disease in patients with end stage renal disease. BMC Nephrol (2014) 0.81
Delayed ipsilateral parenchymal hemorrhage following treatment of intracranial aneurysms with flow diverter. Neuroradiology (2013) 0.81
Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease. Eur J Epidemiol (2015) 0.81
Cerebral amyloid angiopathy: A clinicopathological study of three cases. Ann Indian Acad Neurol (2010) 0.80
Intracerebral hemorrhage and hypertension. Neurol Sci (2008) 0.80
Risk Factors for Lobar and Non-Lobar Intracerebral Hemorrhage in Patients with Vascular Disease. PLoS One (2015) 0.80
Cost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ≥65 Years With Nonvalvular Atrial Fibrillation. Am J Cardiol (2015) 0.80
Perioperative care of a patient with stroke. Int Arch Med (2010) 0.80
Blood Pressure Management After Intracerebral Hemorrhage. Curr Treat Options Neurol (2015) 0.79
Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics. Circulation (2016) 0.78
Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes. J Am Heart Assoc (2015) 0.78
Thrombelastography detects possible coagulation disturbance in patients with intracerebral hemorrhage with hematoma enlargement. Stroke (2014) 0.78
Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke (2017) 0.78
Genetic Associations of Angiotensin-Converting Enzyme with Primary Intracerebral Hemorrhage: A Meta-analysis. PLoS One (2013) 0.77
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin. Europace (2016) 0.77
Childhood hemorrhagic stroke: an important but understudied problem. J Child Neurol (2011) 0.77
Silent New Brain Lesions: Innocent Bystander or Guilty Party? J Stroke (2015) 0.77
Modified Ideal Cardiovascular Health Status is Associated with Lower Prevalence of Stroke in Rural Northeast China. Int J Environ Res Public Health (2016) 0.77
Editorial comment--Minor risk factors for intracerebral hemorrhage: the jury is still out. Stroke (2003) 0.77
Long-term survival following metachronous intratumoral hemorrhage in an HIV-infected patient with lung cancer. Int J Clin Oncol (2010) 0.76
Migraine and hemorrhagic stroke: data from general practice. J Headache Pain (2015) 0.76
Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia. Clin Res Cardiol (2013) 0.76
Increased Risk of Intracranial Hemorrhage in Patients With Pregnancy-Induced Hypertension: A Nationwide Population-Based Retrospective Cohort Study. Medicine (Baltimore) (2016) 0.76
Intracerebral hemorrhage in mouse models: therapeutic interventions and functional recovery. Metab Brain Dis (2014) 0.76
Comparative Effects of α-, β-, and γ-Carbolines on Platelet Aggregation and Lipid Membranes. J Toxicol (2011) 0.76
Smoking as a crucial independent determinant of stroke. Tob Induc Dis (2004) 0.76
Association of ACE gene I/D polymorphism and ACE levels with hemorrhagic stroke: comparison with ischemic stroke. Neurol Sci (2014) 0.75
Hemostatic Markers and Long-Term Risk of Intracerebral Hemorrhage in Postmenopausal Women. J Stroke Cerebrovasc Dis (2016) 0.75
PGE2-EP3 signaling exacerbates intracerebral hemorrhage outcomes in 24-mo-old mice. Am J Physiol Heart Circ Physiol (2016) 0.75
Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences. BMC Health Serv Res (2017) 0.75
Spontaneous intra-cerebral hemorrhage: A retrospective study of risk factors and outcome in a Turkish population. J Neurosci Rural Pract (2013) 0.75
Diabetic aggravation of stroke and animal models. Exp Neurol (2017) 0.75
Statin use and risk of haemorrhagic stroke in a community-based cohort of postmenopausal women: an observational study from the Women's Health Initiative. BMJ Open (2015) 0.75
Higher Rate of Intracerebral Hemorrhage in Hispanic Patients with Cerebral Cavernous Malformation. J Vasc Interv Neurol (2015) 0.75
Multiple Spontaneous Intracerebral Hematoma without Presenting Risk Factors. J Cerebrovasc Endovasc Neurosurg (2016) 0.75
Comparing Risk Factor Profiles between Intracerebral Hemorrhage and Ischemic Stroke in Chinese and White Populations: Systematic Review and Meta-Analysis. PLoS One (2016) 0.75
Association Between Reduced Risk of Intracerebral Hemorrhage and Pelvic Inflammatory Disease. Medicine (Baltimore) (2016) 0.75
Risk of Stroke in Patients With Spontaneous Pneumothorax: A Nationwide, Population-Based Study. Medicine (Baltimore) (2016) 0.75
The persisting burden of intracerebral haemorrhage: can effective treatments be found? PLoS Med (2010) 0.75
Risk of Intracerebral Hemorrhage after Emergency Department Discharges for Hypertension. J Stroke Cerebrovasc Dis (2016) 0.75
ECG changes of cardiac origin in elderly patients with traumatic brain injury. Med J Islam Repub Iran (2015) 0.75
Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide. J Med Econ (2013) 0.75
The critical care management of spontaneous intracranial hemorrhage: a contemporary review. Crit Care (2016) 0.75
Management of intracerebral hemorrhage-use of statins. Vasc Health Risk Manag (2016) 0.75
The outcomes of spontaneous intracerebral hemorrhage in young adults - a clinical study. J Cerebrovasc Endovasc Neurosurg (2013) 0.75
New avenues for treatment of intracranial hemorrhage. Curr Treat Options Cardiovasc Med (2014) 0.75
An ABC for decision making. Radiol Bras (2015) 0.75
Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US. Clinicoecon Outcomes Res (2016) 0.75
Inverse association of plasma level of high-density lipoprotein cholesterol with intracerebral hemorrhage. J Lipid Res (2011) 0.75
Intracranial haemorrhage in thrombocytopenic haematology patients--a nested case-control study: the InCiTe study protocol. BMJ Open (2014) 0.75
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2001) 5.18
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke (1997) 4.13
Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke (1998) 4.12
Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke (1996) 3.67
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry (2007) 3.17
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke (2005) 2.69
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke (1999) 2.49
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology (1998) 2.39
Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review. Neurology (2010) 2.34
Association of intraoperative transcranial doppler monitoring variables with stroke from carotid endarterectomy. Stroke (2000) 2.33
Circle of Willis: morphologic variation on three-dimensional time-of-flight MR angiograms. Radiology (1998) 2.30
Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet (2001) 2.29
Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation (1995) 2.13
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08
Ticlopidine, trials, and torture. Stroke (1994) 2.04
Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone? J Neurol Neurosurg Psychiatry (1999) 2.03
Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain (2005) 1.85
Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke (1998) 1.82
Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology (2000) 1.80
Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage. J Neurosurg (2001) 1.73
Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation (1999) 1.69
Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group. Lancet (1992) 1.68
First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: influence of diagnostic bias. Schizophr Res (2010) 1.68
Risk of subarachnoid haemorrhage according to number of affected relatives: a population based case-control study. Brain (2008) 1.67
Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology (2007) 1.64
Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. BMJ (1995) 1.62
Outcome in familial subarachnoid hemorrhage. Stroke (1995) 1.59
Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia (2007) 1.59
Quality of life after severe bacterial peritonitis and infected necrotizing pancreatitis treated with open management of the abdomen and planned re-operations. Crit Care Med (2001) 1.56
The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost (2003) 1.55
Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study. Circulation (1996) 1.54
Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology (2007) 1.54
Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage. J Clin Pharm Ther (2005) 1.54
Applicability and relevance of models that predict short term outcome after intracerebral haemorrhage. J Neurol Neurosurg Psychiatry (2005) 1.53
Quality of life after infrainguinal bypass grafting surgery. Dutch Bypass Oral Anticoagulants or Aspirin (BOA) Study Group. J Vasc Surg (1999) 1.49
Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke (1997) 1.49
Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology (1996) 1.48
Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol (2001) 1.46
Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series. Acta Psychiatr Scand (2000) 1.45
Predicting outcome after acute basilar artery occlusion based on admission characteristics. Neurology (2012) 1.45
Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis. BMJ (2011) 1.44
Yield of screening for new aneurysms after treatment for subarachnoid hemorrhage. Neurology (2004) 1.43
Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A. J Infect Dis (1993) 1.42
Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry (2005) 1.40
[20,000 kg aspirin and 45 pages British Medical Journal]. Ned Tijdschr Geneeskd (1994) 1.40
[A new instrument to measure clinical outcomes]. Ned Tijdschr Geneeskd (2002) 1.40
Headache characteristics in subarachnoid haemorrhage and benign thunderclap headache. J Neurol Neurosurg Psychiatry (1998) 1.39
[Chronicle of a defective heart valve prosthesis]. Ned Tijdschr Geneeskd (1998) 1.39
[Surgery for a recently symptomatic severe carotid stenosis, indicated or not? Clinical application of 'evidence-based' medicine]. Ned Tijdschr Geneeskd (2001) 1.39
Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry (1992) 1.38
[Carotid endarterectomy indicated in asymptomatic stenosis]. Ned Tijdschr Geneeskd (2004) 1.38
['Neurodevelopmental treatment' following stroke: no beneficial effect shown in measurements taken after 1 year; comparative study]. Ned Tijdschr Geneeskd (2007) 1.38
Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology (1996) 1.38
The prognostic value of domain-specific cognitive abilities in acute first-ever stroke. Neurology (2005) 1.36
Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol (1999) 1.35
Risk factors for subarachnoid hemorrhage: a systematic review. Stroke (1996) 1.35
Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol (2000) 1.35
Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event. J Neurol Neurosurg Psychiatry (2007) 1.35
Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke (1999) 1.30
Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. J Thromb Haemost (2005) 1.29
Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA Trial Study Group. Ann Neurol (1992) 1.23
Endovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2005) 1.23
Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage. Stroke (1998) 1.19
Prognostic scoring systems to predict outcome in peritonitis and intra-abdominal sepsis. Br J Surg (1997) 1.18
Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology (2000) 1.16
Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2004) 1.16
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2005) 1.13
Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev (2005) 1.12
Mayo and NINDS scales for assessment of tendon reflexes: between observer agreement and implications for communication. J Neurol Neurosurg Psychiatry (1998) 1.11
Familial subarachnoid hemorrhage: distinctive features and patterns of inheritance. Ann Neurol (1995) 1.10
Psychosocial impact of finding small aneurysms that are left untreated in patients previously operated on for ruptured aneurysms. J Neurol Neurosurg Psychiatry (2006) 1.10
Cognition after carotid endarterectomy or stenting: a randomized comparison. Neurology (2011) 1.09
Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial. Lancet Neurol (2007) 1.08
Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology (2002) 1.07
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2003) 1.07
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies. Osteoporos Int (2004) 1.07
Carotid stenting: is there an operator effect? A pooled analysis from the carotid stenting trialists' collaboration. Stroke (2013) 1.07
Plasma levels of cellular fibronectin in diabetes. Diabetes Care (2001) 1.06
Reproducibility of measurements of intima-media thickness and distensibility in the common carotid artery. Eur J Vasc Endovasc Surg (1998) 1.04
Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin. J Neurol Neurosurg Psychiatry (1999) 1.04
Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 1.03
Delirium in the acute phase after stroke: incidence, risk factors, and outcome. Neurology (2011) 1.03
New detected aneurysms on follow-up screening in patients with previously clipped intracranial aneurysms: comparison with DSA or CTA at the time of SAH. Stroke (2005) 1.03
Potentials of magnesium treatment in subarachnoid haemorrhage. Magnes Res (2004) 1.02
Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study. Stroke (2006) 1.01